Assessing the Impact of Additional Serratus Anterior Block Within 24-Hour on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients
Launched by AL-QUDS UNIVERSITY · Feb 18, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a new pain management technique works for patients undergoing a specific type of surgery called Video-Assisted Thoracoscopic Surgery (VATS). The researchers want to find out if adding a Serratus Anterior Plane Block (SAPB) to the standard Rhomboid Intercostal Block (RIB) can help control pain better after surgery. They are looking for 50 adults aged 18 to 70 who are scheduled for this surgery and meet certain health criteria. Participants will be divided into two groups: one will receive only the standard pain relief method (RIB), while the other will get both the RIB and the additional SAPB.
During the trial, pain levels and the amount of pain medication used will be measured for up to 48 hours after the surgery. The goal is to see if the combination of these two techniques provides better pain relief and reduces the need for stronger pain medications. Patients who have certain allergies, medical conditions, or who are pregnant will not be eligible to participate. Overall, this study aims to improve the way pain is managed after VATS surgery, helping patients to recover more comfortably.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults aged 18-70 years.
- • 2. Patients undergoing Video-Assisted Thoracoscopic Surgery (VATS).
- • 3. Classified as ASA physical status I-III (low to moderate surgical risk).
- • 4. Ability to provide informed consent and follow study protocols.
- Exclusion Criteria:
- • 1. Known allergy or hypersensitivity to local anesthetics.
- • 2. Presence of bleeding disorders or anticoagulant use.
- • 3. History of chronic opioid use or opioid dependence.
- • 4. Anatomical abnormalities or conditions preventing the application of regional anesthesia (e.g., chest wall deformities).
- • 5. Presence of neurological disorders affecting pain perception.
- • 6. Cognitive impairments, language barriers, or inability to communicate effectively.
- • 7. Pregnancy or breastfeeding.
- • 8. Refusal or inability to provide informed consent.
About Al Quds University
Al-Quds University is a leading academic institution located in Palestine, dedicated to advancing research and education in various fields, including health sciences. The university is committed to fostering innovative clinical research that addresses local and global health challenges. By leveraging its multidisciplinary expertise and collaboration with healthcare professionals, Al-Quds University aims to contribute to evidence-based practices and improve patient outcomes through rigorous clinical trials. With a focus on ethical standards and community engagement, the university strives to enhance the quality of life for diverse populations through its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hebron, , Palestinian Territory, Occupied
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported